GPs in Scotland have wider type-2 diabetes treatment choice

GPs in Scotland now have a wider choice of treatments for type-2 diabetes following acceptance of the dipeptidyl peptidase 4 (DPP-4) inhibitor sitagliptin by the Scottish Medicines Consortium (SMC).

SMC accepted sitagliptin to treat type-2 diabetes in combination with a sulphonylurea and metformin when diet and exercise plus dual therapy with these agents do not provide adequate control of blood sugar. 

It also accepted it for use in combination with a sulphonylurea when diet and exercise plus the highest tolerated dose of sulphonylurea does not provide adequate control of blood sugar and when metformin is not suitable.

The SMC noted that, although sitagliptin is also licensed for use in combination with thiazolidinedione drugs, the manufacturer’s submission related only to the use of sitagliptin in combination with sulphonylureas with or without metformin.

The SMC said it therefore could not recommend the use of sitagliptin in combination with thiazolidinediones.

tom.moberly@haymarket.com

Comment below and tell us what you think

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Follow Us:

Just published

Government outlines PPE supply plans as GPs remain in dark over reimbursement

Government outlines PPE supply plans as GPs remain in dark over reimbursement

The government has outlined plans to provide 'an uninterrupted supply' of PPE during...

Four in five GPs report heavy workload as COVID-19 second wave builds

Four in five GPs report heavy workload as COVID-19 second wave builds

Four in five GPs say their practice is currently facing levels of workload that are...

Medeconomics Live: Bringing you the latest in practice management thinking

Medeconomics Live: Bringing you the latest in practice management thinking

The one-day, virtual Medeconomics Live conference aims to provide essential insights...

First COVID-19 jabs to target care home residents and staff under new JCVI advice

First COVID-19 jabs to target care home residents and staff under new JCVI advice

Older adults living in care homes and staff working there will be first to receive...

GPs unable to veto virtual fitness to practise hearings during pandemic

GPs unable to veto virtual fitness to practise hearings during pandemic

GPs facing fitness to practise investigations during the COVID-19 pandemic will be...

Government rejects major NHSPS overhaul - but changes 'could ease GP service charge disputes'

Government rejects major NHSPS overhaul - but changes 'could ease GP service charge disputes'

A government review has rejected calls for a major overhaul of an NHS Property Services...